The case of a 9-year-old girl with cat-scratch disease (CSD) complicated by development of a paravertebral mass and osteomyelitis is presented. Following multiple scratches and inguinal lymphadenopathy, she developed back pain, and imaging demonstrated a paravertebral mass with evidence of osteomyelitis involving vertebra T9. The diagnosis was made on the basis of detection of Bartonella henselae by use of molecular techniques on an aspirate from the vertebral column and supportive serology for infection with B. henselae. Eleven other cases of this unusual manifestation associated with CSD have been reported in the literature and are reviewed. The patient was treated with gentamicin, followed by rifampicin and trimethoprim-sulfamethoxazole, orally and made a favorable recovery over 7 months. This is comparable with other case reports, regardless of the choice of antibiotic therapy. CSD in immunocompetent hosts is not always self-limiting, and tissues beyond the lymph nodes can be involved.

by fetal blood sampling looking for the evidence of parvovims infection. However, intrauterine transfusion should be reserved for hydropic fetuses with a low haernatwrit. More studies are needed to clarify further the natural history of the infection in the fetus and the long-term sequelae in surviving infants. References1.Guidozzi F, Ballot D. Rothberg AD. Human parvovirus infection in an obstetric population. A prospective study determining fetal outcome. J Reprod Med 1994, 39:36-38. 2. Boyce BF, Forgie I. An outbreak of 'slapped cheek' parvovirus infection (erythema infectiosum) in a Scottish street. Scot Med 3.Schwaru T. Roggendorf M. Hoftenbager B et al. Human pllrvovirus B19 infection in pregnancy. Lancet 1988; 2:566-567. 4. Brandenburg H. Los FJ and Cohen-Overbcek TE. A case of early intrauterine parvovirus B19 infection. Prenat Diagn 1996; 16:75-77. 5. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990. 300: 1166-1 170. 6. Anand A. Gray E. Brown T. Clewlcy J, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987; 316183-186. 7. Towbin JA. Griffin LD. Manin AB et al. Intrauterine adenovkal myocarditis presenting 8s nonimmune hydrops fetalis: diagnosis by polymerase chain reaction. Pediatr Infect Dis J 1994, 13:144-I so. J 1987; 32~70-1 I. 8. Sahakian V, Weiner CP, Naides SJ, Williamson R Scbanxh L. Intrauterine transfusion treatment of mnimmune hydmps EeraIis secondary to human parvovirus B19 infection. Am J Obstn Gynecol1991; 164.1090-1C91. 9. Peters MT, Nim1aide.s KH. Cordccentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gyoecol 1990,75:501-S04. 10. Carrington D, Whittle M, Gibson Aet al. Maternal s e w Alphafetoprotein -a marker of fetal aplastic crisis during intrautexine human parvovhs infection. Lancet 1987; 1:433435. 1. Saller DN, Rogers BB, Canick JA. M a t e d serum biochemical markers associated with fetal parvovirus B19 infection. Rcnat Diagn 1993; 13:467471. 2.Sheikh A, b e s t J, O'Shea M. Long-term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol 1992; 167:337-341. 3. Duthie SJ. Walkinshaw SA. Parvovinrs associated fetal hydrops: reversal of pregnancy induced proteinuric hypertension by in utero fetal transfusion. Br I Obstet Gynaecol 1995; 1021011-1013. 4.Petrikovsky BM, Baker D, Schneider E. Fetal hydrops secondary to human parvovirus infection in early pregnancy. h n a t Diagn 1996; 16342-344. 5. Pryde PG, Nugent CE, Ridijian Get al. Spontaneous resolution of nonimmune hydrops fetalis secondarj to human parvovirus B19 infection. Obstet Gynecol 1992; 79859-861. 16.Kovacs B, Carlson D. Shahbahrami B, Platt L. &natal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction. EDITORIAL COMMENT:We accepted this case forpublication because it seem to link graft versus host disease with intrauterine transfusions. Since the association of transfusion with graft versus host disea...